Akers BioSciences, Inc. Announces Pricing of Approximately $8 Million Public Offering
05 déc. 2019 09h25 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company” or “we”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the...
Akers Biosciences Continues Strategic Review; Explores Leveraging its 30-years of Laboratory Operations to Enter into the Hemp and Minor Cannabinoid Processing Industry
05 déc. 2019 08h45 HE
|
Akers Biosciences Inc.
· Establishes Advisory Board appointing Bob Hoban and Michael Patterson Thorofare, New Jersey, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company” or “we”) (NASDAQ:...
Akers Biosciences Reports Q1 2019 Earnings
20 mai 2019 17h38 HE
|
Akers Biosciences Inc.
Continued Progress Toward Positioning the Company for Strategic Alternatives THOROFARE, N.J., May 20, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (“Akers Bio” or the...
Akers Biosciences Reports Fiscal Year 2018 Earnings
01 avr. 2019 17h31 HE
|
Akers Biosciences Inc.
Ongoing Measures to Streamline Operations, Reduce Costs and Position the Company for Strategic Alternatives THOROFARE, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc....
Akers Biosciences Exploring Potential Business Combinations in Alternative Sectors Including Cannabis Industry
19 nov. 2018 09h01 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, is...
Akers Biosciences Announces Q3 2018 Earnings
15 nov. 2018 07h00 HE
|
Akers Biosciences Inc.
Sales of Flagship PIFA Heparin PF/4 Rapid Assay Products Up 16% over Q3 2017; Company Continuing to Evaluate Strategic Alternatives to Maximize Shareholder Value THOROFARE, N.J., Nov. 15, 2018 ...
Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value
07 nov. 2018 09h15 HE
|
Akers Biosciences Inc
Announces 1:8 Reverse Stock Split THOROFARE, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid...
Akers Biosciences to Present at Disruptive Growth & Healthcare Conference
08 févr. 2016 12h18 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), (“Akers Bio” or the "Company"), a developer of cutting edge technologies that deliver rapid...
Akers Biosciences Appoints Medical Technology Specialist as CEO
23 nov. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of...
Akers Biosciences Announces Q3 2015 Earnings
13 nov. 2015 07h00 HE
|
Akers Biosciences Inc.
Flagship Rapid HIT Test Set to be in 250 US Hospitals by Year End
Conference Call Scheduled for 9:00 a.m. EST Today
THOROFARE, N.J., Nov. 13, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc....